Scarica l'app Stockscreener
5.23
3.16%
0.16
Aldeyra Therapeutics Inc Azioni (ALDX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Research and Development |
14.57%
8.5052
|
7.4233 | 12.44 | 14.97 | 6.1835 |
| Operating Income/Loss |
2.48%
-10.17
|
-10.43 | -16.14 | -18.01 | -9.3939 |
| Nonoperating Income/Loss |
19.39%
0.4014
|
0.498 | 1.0246 | 1.1602 | 1.3117 |
| Income/Loss From Continuing Operations Before Tax |
1.63%
-9.7673
|
-9.9295 | -15.11 | -16.85 | -8.0821 |
| Income/Loss From Continuing Operations After Tax |
1.63%
-9.7673
|
-9.9295 | -15.11 | -16.85 | -8.0821 |
Net Income/Loss
|
1.63%
-9.7673
|
-9.9295 | -15.11 | -16.85 | -8.0821 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.26%
60.05
|
59.89 | 59.53 | 59.41 | 59.41 |
| Diluted Average Shares |
0.26%
60.05
|
59.89 | 59.53 | 59.41 | 59.41 |
| Basic Earnings Per Share |
5.88%
-0.16
|
-0.17 | -0.25 | -0.28 | -0.14 |
| Diluted Earnings Per Share |
5.88%
-0.16
|
-0.17 | -0.25 | -0.28 | -0.14 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):